ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 229 filers reported holding ABERDEEN STD GOLD ETF TR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,361,976 | +0.7% | 61,295 | -3.7% | 0.02% | -5.3% |
| Q1 2024 | $1,352,372 | -16.7% | 63,671 | -22.6% | 0.02% | -24.0% |
| Q4 2023 | $1,623,418 | +3.3% | 82,240 | -7.4% | 0.02% | -10.7% |
| Q3 2023 | $1,571,650 | -14.1% | 88,844 | -10.8% | 0.03% | -15.2% |
| Q2 2023 | $1,830,424 | +5.8% | 99,642 | +7.0% | 0.03% | +10.0% |
| Q1 2022 | $1,730,000 | -29.9% | 93,097 | -33.7% | 0.03% | -31.8% |
| Q4 2021 | $2,467,000 | -61.8% | 140,467 | -63.3% | 0.04% | -62.4% |
| Q3 2021 | $6,454,000 | -2.4% | 383,035 | -1.6% | 0.12% | -8.6% |
| Q2 2021 | $6,613,000 | -31.3% | 389,230 | -33.7% | 0.13% | -39.9% |
| Q1 2021 | $9,632,000 | -11.0% | 587,293 | -0.8% | 0.21% | -18.4% |
| Q4 2020 | $10,825,000 | -4.2% | 592,193 | -4.9% | 0.26% | -23.9% |
| Q3 2020 | $11,304,000 | -5.3% | 622,819 | -10.6% | 0.34% | -16.1% |
| Q2 2020 | $11,941,000 | – | 696,681 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Wealth Management, LLC | 1,847,358 | $31,128,000 | 4.98% |
| UBP Investment Advisors SA | 714,134 | $12,030,000 | 4.67% |
| swisspartners Ltd. | 305,000 | $5,140,000 | 3.98% |
| Hudock, Inc. | 610,696 | $10,290,000 | 3.10% |
| Newman Dignan & Sheerar, Inc. | 583,831 | $9,838,000 | 2.84% |
| Allen Capital Group, LLC | 605,015 | $10,195,000 | 2.05% |
| American Money Management, LLC | 299,061 | $5,039,000 | 1.42% |
| Cypress Capital, LLC | 574,350 | $9,678,000 | 1.23% |
| COLLECTIVE FAMILY OFFICE LLC | 156,821 | $2,642,000 | 1.14% |
| WOLFF WIESE MAGANA LLC | 93,962 | $1,583,000 | 1.12% |